Clinicopathological Profile of Salivary Gland Tumors in a Tertiary Care Setting in Odisha: A Retrospective Analysis

Authors

Jyotiranjan Mohapatra  1 , Bagmi Mishra  2 , Subrat Samantara  3 , Snehasis Pradhan  4 , Muhammed Navas NK  5
Assistant Professor, Department of General Surgery, Shri Jagannath Medical College and Hospital, Puri, Odisha, India. 1 , Assistant Professor, Department of Pathology, SUM Hospital, Bhubaneswar, Odisha, India. 2 , Associate Professor, Department of Surgical Oncology, A.H Post Graduate Institute of Cancer, Cuttack, Odisha, India. 3 , Associate Professor, Department of Surgical Oncology, IMS & SUM Hospital, Bhubaneswar, Odisha, India. 4 , Surgical oncologist, Surgical oncologist, Iqraa Hospital, Calicut, Kerala. India. 5
“crossref”/
Views: 12  
Downloads: 13  

##plugins.themes.bootstrap3.article.sidebar##

PDF
Published: 2025-05-15
DOI: 10.5281/
Keywords:
Salivary gland tumors epidemiology head and neck pathology

##plugins.themes.bootstrap3.article.main##

Abstract

Background: Salivary gland neoplasms, characterized by significant histological heterogeneity and originating from any major (parotid, submandibular, sublingual) or minor salivary gland within the oral cavity and upper aerodigestive tract, were the subject of this retrospective study. The objective was to delineate the clinicopathological features of these tumors within a patient cohort from a tertiary care teaching hospital in coastal Odisha. Material and Methods: This study employed a retrospective, descriptive, cross-sectional design (2022-2024) to examine surgically diagnosed salivary gland tumors (SGTs), with subsequent collection of relevant clinicopathological information. Results: In this retrospective study of 150 diagnosed salivary gland tumors (SGTs), representing 1.31% of total diagnoses, a predominance of benign lesions (67.33%) was observed. The patient cohort exhibited a near-equal sex distribution, with a mean age of 55.5 years. The parotid gland was the most frequent site of tumor occurrence, followed by the palate and submandibular gland. Pleomorphic adenoma and mucoepidermoid carcinoma were the most commonly identified benign and malignant histotypes, respectively. Subsequent re-evaluation using updated WHO criteria resulted in the reclassification of 4.0% of cases. Conclusions: The clinicopathological characteristics of salivary gland tumors observed in this cohort aligned with findings reported in international literature, demonstrating a lack of sex-based predilection. While morphological evaluation remains paramount for initial diagnosis, immunohistochemical analysis is crucial for definitive diagnosis, particularly in diagnostically challenging cases.

##plugins.themes.bootstrap3.article.details##

Clinicopathological Profile of Salivary Gland Tumors in a Tertiary Care Setting in Odisha: A Retrospective Analysis. (2025). Annals of Medicine and Medical Sciences, 351-355. https://doi.org/10.5281/
Original Article

Copyright (c) 2025 Jyotiranjan Mohapatra, Bagmi Mishra, Subrat Samantara, Snehasis Pradhan, Muhammed Navas NK

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Creative Commons License All articles published in Annals of Medicine and Medical Sciences are licensed under a Creative Commons Attribution 4.0 International License.

[1] Cunha JLS, Hernandez-Guerrero JC, de Almeida OP, Soares CD, Mosqueda-Taylor A. Salivary gland tumors: a retrospective study of164 cases from a single private practice service in Mexico and literatu- re review. Head Neck Pathol. 2021;15:523-531.

[2] Skálová A, Hyrcza MD, Leivo I. Update from the 5th Edition of the World Health Organization Classification of Head and Neck Tumors: Salivary Glands. Head Neck Pathol. 2022;16:40-53.

[3] Cunha JL, Coimbra AC, Silva JV, Nascimento IS, Andrade ME, Oli- veira CR, et al. Epidemiologic analysis of salivary gland tumors over a 10-years period diagnosed in a northeast Brazilian population. Med Oral Patol Oral Cir Bucal. 2020;25:e516-e522.

[4] Silva LP, Serpa MS, Viveiros SK, Sena DAC, Pinho RFC, Gui- marães LDA, et al. Salivary gland tumors in a Brazilian population: A 20-year retrospective and multicentric study of 2292 cases. J Cranio- maxillofac Surg. 2018;46:2227-2233.

[5] Tian Z, Li L, Wang L, Hu Y, Li J. Salivary gland neoplasms in oral and maxillofacial regions: a 23-year retrospective study of 6982 cases in an eastern Chinese population. Int J Oral Maxillofac Surg. 2010;39:235-42.

[6] Vasconcelos AC, Nör F, Meurer L, Salvadori G, Souza LB, Vargas PA, et al. Clinicopathological analysis of salivary gland tumors over a 15- year period. Braz Oral Res. 2016;30:pii:S1806-83242016000100208.

[7] Bittar RF, Ferraro HP, Moraes Gonçalves FT, Couto da Cun- ha MG, Biamino ER. Neoplasms of the salivary glands: analysis of 727 histopathological reports in a single institution. Otolaryngol Pol. 2015;69:28-33.

[8] Wang XD, Meng LJ, Hou TT, Huang SH. Tumours of the salivary glands in northeastern China: a retrospective study of 2508 patients. Br J Oral Maxillofac Surg. 2015;53:132-7.

[9] Gao M, Hao Y, Huang MX, Ma DQ, Chen Y, Luo HY, et al. Salivary gland tumours in a northern Chinese population: a 50-year retrospecti- ve study of 7190 cases. Int J Oral Maxillofac Surg. 2017;46:343-349.

[10] Mejía-Velázquez CP, Durán-Padilla MA, Gómez-Apo E, Que- zada-Rivera D, Gaitán-Cepeda LA. Tumors of the salivary gland in mexicans. A retrospective study of 360 cases. Med Oral Patol Oral Cir Bucal. 2012;17:e183-e189.

[11] Noel L, Medford S, Islam S, Muddeen A, Greaves W, Juman S. Epidemiology of salivary gland tumours in an Eastern Caribbean na- tion: A retrospective study. Ann Med Surg (Lond). 2018;36:148-151.

[12] Reinheimer A, Vieira DS, Cordeiro MM, Rivero ER. Retrospective study of 124 cases of salivary gland tumors and literature review. J Clin Exp Dent. 2019;11:e1025-e1032.

[13] Taghavi N, Sargolzaei S, Mashhadiabbas F, Akbarzadeh A, Kar- douni P. Salivary gland tumors: A 15- year report from Iran. Turk Pa- toloji Derg. 2016;32:35-39.

[14] Araya J, Martinez R, Niklander S, Marshall M, Esguep A. Inciden- ce and prevalence of salivary gland tumours in Valparaiso. Chile. Med Oral Patol Oral Cir Bucal. 2015;20:e532-e539.

[15] Lopes MLDS, Barroso KMA, Henriques ÁCG, Dos Santos JN, Martins MD, de Souza LB. Pleomorphic adenomas of the salivary glands: retrospective multicentric study of 130 cases with emphasis on histopathological features. Eur Arch Otorhinolaryngol. 2017;274:543- 551.

[16] Fomete B, Adebayo ET, Ononiwu CN. Management of sali- vary gland tumors in a Nigerian tertiary institution. Ann Afr Med. 2015;14:148-54.

[17] Lawal AO, Adisa AO, Kolude B, Adeyemi BF, Olajide MA. A re- view of 413 salivary gland tumours in the head and neck region. J Clin Exp Dent. 2013;5:e218-e222222.

[18] Gontarz, M.; Bargiel, J.; Gąsiorowski, K.; Marecik, T.; Szczurowski, P.; Zapała, J.; Wyszyńska-Pawelec, G. Epidemiology of Primary Epithelial Salivary Gland Tumors in Southern Poland-A 26-Year, Clinicopathologic, Retrospective Analysis. J. Clin. Med. 2021, 10, 1663.

[19] Sentani K, Ogawa I, Ozasa K, Sadakane A, Utada M, Tsuya T, Ka- jihara H, Yonehara S, Takeshima Y, Yasui W. Characteristics of 5015 salivary gland neoplasms registered in the Hiroshima tumor tissue re- gistry over a period of 39 years. J Clin Med. 2019;8:566.

[20] Srinivas CV. Carcinoma Ex-pleomorphic Adenoma: A Case for Cure. Int J Head Neck Surg 2020;11(2):32-35.

[21] Di Palma S. Carcinoma ex pleomorphic adenoma, with particular emphasis on early lesions. Head Neck Pathol. 2013;7:S68-S76.

[22] Díaz KP, Gondak R, Martins LL, de Almeida OP, León JE, Ma- riano FV, Altemani A, Vargas PA. Fatty acid synthase and Ki-67 immunoexpression can be useful for the identification of malignant component in carcinoma ex-pleomorphic adenoma. J Oral Pathol Med. 2019;48:232-238.

[23] Seethala RR, Stenman G. Update from the 4th Edition of the World Health Organization Classification of Head and Neck Tumours: tu- mors of the salivary gland. Head Neck Pathol. 2017;11:55-67.

[24] Michal M, Kacerovska D, Kazakov DV. Cribriform adenocarcinoma of the tongue and minor salivary glands: a review. Head Neck Pathol. 2013 Jul;7 Suppl 1(Suppl 1):S3-11. doi: 10.1007/s12105-013-0457-9. Epub 2013 Jul 3.

[25] Skalova A, Sima R, Kaspirkova-Nemcova J, Simpson RH, Elm- berger G, Leivo I, et al. Cribriform adenocarcinoma of minor salivary gland origin principally affecting the tongue: characterization of new entity. Am J Surg Pathol. 2011;35:1168-76.

[26] Weinreb I, Zhang L, Tirunagari LM, Sung YS, Chen CL, Perez-Or- donez B, et al. Novel PRKD gene rearrangements and variant fusions in cribriform adenocarcinoma of salivary gland origin. Genes Chro- mosomes Cancer. 2014;53:845-56.

[27] Weinreb I, Piscuoglio S, Martelotto LG, Waggott D, Ng CK, Pe- rez-Ordonez B, et al. Hotspot activating PRKD1 somatic mutations in polymorphous low-grade adenocarcinomas of the salivary glands. Nat Genet. 2014;46:1166-9.

[28] Weinreb I, Chiosea SI, Seethala RR, Reis-Filho JS, Weigelt B, Pis- cuoglio S, et al. Genotypic and phenotypic comparison of polymor- phous and cribriform adenocarcinomas of salivary gland. Mod Pathol. 2015;28:333.

[29] Mahomed Y, Meer S. Primary epithelial minor salivary gland tumors in south Africa: a 20-year review. Head Neck Pathol. 2020;14:715-723.

[30] Lukšić I, Virag M, Manojlović S, Macan D. Salivary gland tu- mours: 25 years of experience from a single institution in Croatia. J Craniomaxillofac Surg. 2012;40:e75-81.